Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Zenith Drugs Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
93.75
1600
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
1600
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Zenith Drugs Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Zenith Drugs has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Zenith Drugs - Updates
-
Zenith Drugs - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Zenith Drugs - Board Meeting Intimation
-
Zenith Drugs - Board Meeting Intimation
-
Zenith Drugs - Trading Window
-
Zenith Drugs - Trading Window-XBRL
-
Zenith Drugs - Trading Window-XBRL
-
Zenith Drugs - General Updates
-
Zenith Drugs - General Updates
-
Zenith Drugs - General Updates
-
Zenith Drugs - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Zenith Drugs - Change in Auditors
Key fundamentals
Evaluate the intrinsic value of Zenith Drugs Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 86.1516 | 43.1509 | 29.6382 | 25.1191 | 18.6447 |
| Liabilities | 86.1516 | 43.1509 | 29.6382 | 25.1191 | 18.6447 |
| Equity | 17.1488 | 0.4 | 0.4 | 0.4 | 0.4 |
| Gross Profit | 16.9219 | 9.0501 | 6.9225 | 7.1987 | 7.0459 |
| Net Profit | 9.5369 | 4.8811 | 3.2129 | 3.0665 | 3.3998 |
| Cash From Operating Activities | -12.4903 | -4.2679 | 4.9081 | -0.8874 | 3.4762 |
| NPM(%) | 7.24 | 4.26 | 3.5 | 4.17 | 4.34 |
| Revenue | 131.6197 | 114.5191 | 91.655 | 73.4017 | 78.2725 |
| Expenses | 114.6978 | 105.469 | 84.7325 | 66.203 | 71.2266 |
| ROE(%) | 15.31 | 7.83 | 5.16 | 4.92 | 5.46 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 17 Sep 2024 | 0.5 | 5 | 0 | 67.75 |
Peers
Other companies within the same industry or sector that are comparable to Zenith Drugs Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 840.85 | 0.23 | 11.87 | 0.00 | 1321.50 | 1.37 |
| Lotus Eye Hospital and Institute Ltd | 81.36 | 2.94 | 339.00 | 0.00 | 14.01 | 0.61 |
| Vaishali Pharma Ltd | 13.72 | -0.15 | 457.33 | 0.00 | 2.76 | 0.00 |
| Astec Lifesciences Ltd | 693.05 | -1.61 | 0.00 | 0.00 | -687.11 | 0.00 |
Company Info
Our Company was originally incorporated on November 15, 2000 as a Private Limited Company in the name of "Zenith Drugs Private Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Madhya Pradesh, Gwalior. Subsequently pursuant to a Special Resolution of our Shareholders passed in the Extra-Ordinary General Meeting held on September 05, 2023, our Company was converted from a Private Limited Company to Public Limited Company and consequently, the name of our Company was changed to `Zenith Drugs Limited' and a Fresh Certificate of Incorporation consequent to Conversion was issued on September 13, 2023 by the Registrar of Companies, Gwalior.MAJOR EVENTS AND MILESTONES:2000-Incorporation of the Company.2001-Started as a manufacturing house for oral and external formulations.2004-Shifted to a Schedule M GMP compliant unit.-Started the production of two lines which are liquid orals and ointments.2007-Started manufacturing ORS Powder2016-Received WHO GMP certification2019-Turnover crossed 50 Crores.2020-Turnover crossed 75 Crores.2021-Certificate of Quality Management System ISO 9001:2015 issued by Global Grading Certification-Certificate of compliance with good manufacturing practices issued by Liberia Medicines and Health Products Regulatory Authority-Our Company received subsidy under Madhya Pradesh MSME Yojna i.e. MSME Promotion Scheme,2019 as Industrial Development Grant upto 40% of the capital invested in machinery i.e. grant of ? 170.04 Lakhs2022-The Company was recognized as among top 10 MSME Pharmaceutical Manufacturers in Indore in Industry Outlook Magazine Edition.2023-Turnover crossed 100 Crores.-Collaborated with Mr. Kshatriya Valtaprasad Nandkishore for Carrying out the task of Marketing and Export of the products manufactured by Zenith.-Conversion of our Company from Private Limited Company to Public Limited Company. 2024 -"Zenith Drugs has been awarded Tenders issued by the Uttar Pradesh Medical Supplies Corporation Limited."
Our Company was originally incorporated on November 15, 2000 as a Private Limited Company in the name of "Zenith Drugs Private Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Madhya Pradesh, Gwalior. Subsequently pursuant to a Special Resolution of our Shareholders passed in the Extra-Ordinary General Meeting held on September 05, 2023, our Company was converted from a Private Limited Company to Public Limited Company and consequently, the name of our Company was changed to `Zenith Drugs Limited' and a Fresh Certificate of Incorporation consequent to Conversion was issued on September 13, 2023 by the Registrar of Companies, Gwalior.MAJOR EVENTS AND MILESTONES:2000-Incorporation of the Company.2001-Started as a manufacturing house for oral and external formulations.2004-Shifted to a Schedule M GMP compliant unit.-Started the production of two lines which are liquid orals and ointments.2007-Started manufacturing ORS Powder2016-Received WHO GMP certification2019-Turnover crossed 50 Crores.2020-Turnover crossed 75 Crores.2021-Certificate of Quality Management System ISO 9001:2015 issued by Global Grading Certification-Certificate of compliance with good manufacturing practices issued by Liberia Medicines and Health Products Regulatory Authority-Our Company received subsidy under Madhya Pradesh MSME Yojna i.e. MSME Promotion Scheme,2019 as Industrial Development Grant upto 40% of the capital invested in machinery i.e. grant of ? 170.04 Lakhs2022-The Company was recognized as among top 10 MSME Pharmaceutical Manufacturers in Indore in Industry Outlook Magazine Edition.2023-Turnover crossed 100 Crores.-Collaborated with Mr. Kshatriya Valtaprasad Nandkishore for Carrying out the task of Marketing and Export of the products manufactured by Zenith.-Conversion of our Company from Private Limited Company to Public Limited Company. 2024 -"Zenith Drugs has been awarded Tenders issued by the Uttar Pradesh Medical Supplies Corporation Limited."
Read More
Parent Organisation
Zenith Drugs Ltd.
Founded
15/11/2000
Managing Director
Mr.Sandeep Bhardwaj
NSE Symbol
ZENITHDRUGST
FAQ
The current price of Zenith Drugs Ltd is
The 52-week high for Zenith Drugs Ltd is
The market capitalization of Zenith Drugs Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Zenith Drugs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Zenith Drugs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Zenith Drugs Ltd shares.
The CEO of Zenith Drugs Ltd is Mr.Sandeep Bhardwaj, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
